Giuseppe M C Rosano Selected Research

Giuseppe M C Rosano Research Topics

Disease

71	Heart Failure 04/2024 - 01/2008
16	Coronary Artery Disease (Coronary Atherosclerosis) 06/2010 - 01/2002
14	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 02/2002
12	Type 2 Diabetes Mellitus (MODY) 04/2024 - 11/2003
11	Myocardial Ischemia (Ischemic Heart Diseases) 08/2016 - 11/2003
10	Atrial Fibrillation 04/2024 - 01/2011
7	Myocardial Infarction 04/2024 - 05/2006
7	Stroke (Strokes) 04/2024 - 09/2004
7	Obesity 04/2024 - 06/2010
7	Insulin Resistance 01/2012 - 12/2003
6	Hypertension (High Blood Pressure) 01/2023 - 01/2008
5	Heart Diseases (Heart Disease) 01/2023 - 10/2004
5	Inflammation (Inflammations) 12/2021 - 04/2005
5	Cardiomyopathies (Cardiomyopathy) 01/2019 - 11/2003
5	Erectile Dysfunction 03/2011 - 11/2003
4	Iron Deficiencies 01/2023 - 11/2021
4	Stable Angina 01/2019 - 01/2009
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2012 - 03/2004
4	Atherosclerosis 01/2009 - 04/2005
3	Hypotension (Low Blood Pressure) 03/2024 - 01/2022
3	Diabetes Mellitus 01/2023 - 09/2006
3	COVID-19 12/2022 - 01/2022
3	Coronary Disease (Coronary Heart Disease) 01/2019 - 12/2006
3	Ischemia 01/2008 - 09/2006
3	Left Ventricular Dysfunction 11/2007 - 11/2005
2	Chronic Renal Insufficiency 04/2024 - 10/2023
2	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 12/2023 - 01/2022
2	Neoplasms (Cancer) 12/2023 - 12/2015
2	Overweight 12/2022 - 01/2022
2	Hyperkalemia 12/2021 - 12/2015
2	Fibrosis (Cirrhosis) 01/2020 - 12/2015
2	Chest Pain (Chest Pains) 07/2017 - 02/2002
2	Unstable Angina 12/2015 - 02/2002
2	Hypogonadism (Hypergonadotropic Hypogonadism) 11/2015 - 01/2012
1	Transient Ischemic Attack 04/2024
1	Second Primary Neoplasms (Neoplasms, Second) 12/2023
1	Kidney Diseases (Kidney Disease) 10/2023
1	Renal Insufficiency (Renal Failure) 10/2023

Drug/Important Bio-Agent (IBA)

14	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 11/2003
14	Trimetazidine (Vastarel)IBA 01/2019 - 11/2003
8	Natriuretic PeptidesIBA 07/2023 - 10/2020
7	SodiumIBA 04/2024 - 10/2016
7	Estrogens (Estrogen)FDA Link 01/2009 - 01/2002
6	Biomarkers (Surrogate Marker)IBA 07/2023 - 08/2011
6	Testosterone (Sustanon)FDA Link 11/2015 - 01/2009
5	Sodium-Glucose Transport ProteinsIBA 04/2024 - 01/2022
5	Mineralocorticoid Receptor AntagonistsIBA 03/2024 - 12/2015
5	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2023 - 11/2016
5	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2020
4	IvabradineIBA 10/2023 - 04/2010
4	Progestins (Progestagens)IBA 12/2022 - 11/2003
4	SymportersIBA 01/2021 - 01/2020
4	Insulin (Novolin)FDA Link 12/2020 - 05/2005
4	pro-brain natriuretic peptide (1-76)IBA 10/2020 - 11/2016
4	Estradiol (Delestrogen)FDA LinkGeneric 01/2012 - 10/2002
4	Hormones (Hormone)IBA 01/2009 - 03/2004
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 04/2024 - 01/2022
3	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 04/2024 - 01/2008
3	DiureticsIBA 04/2024 - 01/2018
3	Angiotensin Receptors (Angiotensin II Receptor)IBA 03/2024 - 06/2010
3	empagliflozinIBA 12/2023 - 01/2020
3	IronIBA 01/2023 - 11/2021
3	Antihypertensive Agents (Antihypertensives)IBA 09/2019 - 03/2004
3	NitratesIBA 01/2019 - 02/2005
3	Sildenafil Citrate (Viagra)FDA Link 06/2007 - 11/2003
3	C-Reactive ProteinIBA 09/2005 - 09/2004
3	Interleukin-6 (Interleukin 6)IBA 09/2005 - 09/2004
2	Glucagon-Like Peptide 1 (GLP 1)IBA 04/2024 - 12/2022
2	Neprilysin (Neutral Endopeptidase)IBA 03/2024 - 01/2022
2	CreatinineIBA 03/2024 - 01/2018
2	vericiguatIBA 01/2023 - 11/2022
2	Digoxin (Digitek)FDA LinkGeneric 12/2022 - 01/2018
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 12/2020
2	Cardiovascular AgentsIBA 12/2021 - 12/2016
2	Peptides (Polypeptides)IBA 01/2021 - 03/2007
2	dapagliflozinIBA 11/2020 - 01/2020
2	CanagliflozinIBA 11/2020 - 01/2020
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2019 - 01/2009
2	Ranolazine FDA Link 01/2019 - 08/2016
2	Nicorandil (SG 75)IBA 01/2019 - 01/2009
2	Warfarin (Coumadin)FDA LinkGeneric 01/2018 - 11/2016
2	Ezetimibe (Zetia)FDA Link 01/2018 - 12/2015
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 11/2014
2	tiboloneIBA 01/2017 - 09/2005
2	Dipeptidyl-Peptidase IV InhibitorsIBA 10/2016 - 04/2016
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2016 - 12/2011
2	Atenolol (Tenormin)FDA LinkGeneric 09/2013 - 11/2003
2	Carvedilol (Coreg)FDA LinkGeneric 09/2011 - 01/2011
2	Telmisartan (Micardis)FDA Link 06/2010 - 05/2005
2	Oxygen (Dioxygen)IBA 01/2009 - 01/2008
2	Nonesterified Fatty Acids (NEFA)IBA 08/2007 - 11/2005
2	Endothelin-1 (Endothelin 1)IBA 03/2007 - 10/2002
2	LipidsIBA 05/2005 - 06/2003
2	CholesterolIBA 10/2003 - 01/2002
1	Dietary SodiumIBA 04/2024

Therapy/Procedure

53	Therapeutics 04/2024 - 11/2003
5	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2009 - 01/2002
3	Drug Therapy (Chemotherapy) 01/2019 - 12/2016
2	Percutaneous Coronary Intervention 08/2016 - 11/2007
1	Renal Dialysis (Hemodialysis) 10/2023